Incretins: Their physiology and application in the treatment of diabetes mellitus
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Incretins: Their physiology and application in the treatment of diabetes mellitus
Authors
Keywords
-
Journal
DIABETES-METABOLISM RESEARCH AND REVIEWS
Volume 30, Issue 5, Pages 354-371
Publisher
Wiley
Online
2013-12-04
DOI
10.1002/dmrr.2501
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical effects of once-weekly exenatide for the treatment of type 2 diabetes mellitus
- (2013) G. J. Ryan et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors
- (2013) A. E. Butler et al. DIABETES
- Comment on: Butler et al. Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors. Diabetes 2013;62:2595-2604
- (2013) S. S. Engel et al. DIABETES
- Comment on: Butler et al. Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors. Diabetes 2013;62:2595-2604
- (2013) R. J. Heine et al. DIABETES
- Incretin dysfunction in type 2 diabetes: Clinical impact and future perspectives
- (2013) B. Ahrén DIABETES & METABOLISM
- Do GLP-1-Based Therapies Increase Cancer Risk?
- (2013) M. A. Nauck et al. DIABETES CARE
- Update of mortality attributable to diabetes for the IDF Diabetes Atlas: Estimates for the year 2011
- (2013) DIABETES RESEARCH AND CLINICAL PRACTICE
- AACE Comprehensive Diabetes Management Algorithm 2013 Endocrine Practice
- (2013) Héctor Tamez-Pérez et al. Endocrine Practice
- American Association of Clinical Endocrinologists' Comprehensive Diabetes Management Algorithm 2013 Consensus Statement
- (2013) Alan Garber et al. Endocrine Practice
- Clinical utility of insulin and insulin analogs
- (2013) Ahter D. Sanlioglu et al. Islets
- Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus
- (2013) Sonal Singh et al. JAMA Internal Medicine
- Pancreatitis: A Potential Complication of Liraglutide?
- (2012) Andrea S Franks et al. ANNALS OF PHARMACOTHERAPY
- GLP-1 Receptor Agonist Effects on Normal and Neoplastic Pancreata
- (2012) Michael Goggins DIABETES
- Chronic GLP-1 Receptor Activation by Exendin-4 Induces Expansion of Pancreatic Duct Glands in Rats and Accelerates Formation of Dysplastic Lesions and Chronic Pancreatitis in the KrasG12DMouse Model
- (2012) Belinda Gier et al. DIABETES
- The Human GLP-1 Analog Liraglutide and the Pancreas
- (2012) Niels C.B. Nyborg et al. DIABETES
- GLP-1–Based Therapies and the Exocrine Pancreas: More Light, or Just More Heat?
- (2012) Edwin A.M. Gale DIABETES
- No evidence of drug-induced pancreatitis in rats treated with exenatide for 13 weeks
- (2012) K. Tatarkiewicz et al. DIABETES OBESITY & METABOLISM
- Impairment of GLP1-induced insulin secretion: role of genetic background, insulin resistance and hyperglycaemia
- (2012) S. Herzberg-Schäfer et al. DIABETES OBESITY & METABOLISM
- By the numbers: New estimates from the IDF Diabetes Atlas Update for 2012
- (2012) Leonor Guariguata DIABETES RESEARCH AND CLINICAL PRACTICE
- A Review on the Association between Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Cancer
- (2012) Wei-Yih Chiu et al. Experimental Diabetes Research
- Insulin gene therapy from design to beta cell generation
- (2012) Ahter D. Sanlioglu et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- GLP1-derived nonapeptide GLP1(28–36)amide protects pancreatic β-cells from glucolipotoxicity
- (2012) Zhengu Liu et al. JOURNAL OF ENDOCRINOLOGY
- Therapeutic potential of VIP vs PACAP in diabetes
- (2012) Ahter D Sanlioglu et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Incretin-based therapies for type 2 diabetes mellitus: a review of direct comparisons of efficacy, safety and patient satisfaction
- (2012) Sheldon Russell International Journal of Clinical Pharmacy
- Acute Pancreatitis Associated with Liraglutide
- (2011) Phillip H Lee et al. ANNALS OF PHARMACOTHERAPY
- Activation of the GLP-1 Receptor Signalling Pathway: A Relevant Strategy to Repair a Deficient Beta-Cell Mass
- (2011) Bernard Portha et al. Experimental Diabetes Research
- Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies
- (2011) Michael Elashoff et al. GASTROENTEROLOGY
- The Safety of Incretin-Based Therapies—Review of the Scientific Evidence
- (2011) Daniel J. Drucker et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- GLP-1 and Calcitonin Concentration in Humans: Lack of Evidence of Calcitonin Release from Sequential Screening in over 5000 Subjects with Type 2 Diabetes or Nondiabetic Obese Subjects Treated with the Human GLP-1 Analog, Liraglutide
- (2011) Laszlo Hegedüs et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Incretin Receptors in Non-Neoplastic and Neoplastic Thyroid C Cells in Rodents and Humans: Relevance for Incretin-Based Diabetes Therapy
- (2011) Beatrice Waser et al. NEUROENDOCRINOLOGY
- GLP-1 analogs containing disulfide bond exhibited prolonged half-life in vivo than GLP-1
- (2011) Ying Li et al. PEPTIDES
- Clinical Implications of Exenatide as a Twice-Daily or Once-Weekly Therapy for Type 2 Diabetes
- (2011) Vanita R. Aroda et al. POSTGRADUATE MEDICINE
- Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents
- (2010) Krystyna Tatarkiewicz et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Association of Pancreatitis with Glucagon-Like Peptide-1 Agonist Use
- (2010) Sarah L Anderson et al. ANNALS OF PHARMACOTHERAPY
- GLP-1-Based Therapy for Diabetes: What You Do Not Know Can Hurt You
- (2010) P. C. Butler et al. DIABETES CARE
- Glucagon-Like Peptide-1 Receptor Agonists Activate Rodent Thyroid C-Cells Causing Calcitonin Release and C-Cell Proliferation
- (2010) Lotte Bjerre Knudsen et al. ENDOCRINOLOGY
- Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis
- (2010) S. S. Engel et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Weighing Risks and Benefits of Liraglutide — The FDA's Review of a New Antidiabetic Therapy
- (2010) Mary Parks et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thyroid Cancer Incidence Patterns in the United States by Histologic Type, 1992–2006
- (2010) Briseis Aschebrook-Kilfoy et al. THYROID
- Glucagon-Like Peptide-1 Receptor Activation Modulates Pancreatitis-Associated Gene Expression But Does Not Modify the Susceptibility to Experimental Pancreatitis in Mice
- (2009) J. A. Koehler et al. DIABETES
- Potential of Albiglutide, a Long-Acting GLP-1 Receptor Agonist, in Type 2 Diabetes: A randomized controlled trial exploring weekly, biweekly, and monthly dosing
- (2009) J. Rosenstock et al. DIABETES CARE
- Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas
- (2009) J. S. Nachnani et al. DIABETOLOGIA
- Collateral damage: the conundrum of drug safety
- (2009) E. A. M. Gale DIABETOLOGIA
- Pancreatic Duct Glands Are Distinct Ductal Compartments That React to Chronic Injury and Mediate Shh-Induced Metaplasia
- (2009) Oliver Strobel et al. GASTROENTEROLOGY
- Glucose Sensing in L Cells: A Primary Cell Study
- (2008) Frank Reimann et al. Cell Metabolism
- Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways
- (2008) Kiwon Ban et al. CIRCULATION
- Pharmacokinetics and Pharmacodynamic Effects of Oral GLP-1 and PYY3-36: A Proof-of-concept Study in Healthy Subjects
- (2008) C Beglinger et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Gpr40 Is Expressed in Enteroendocrine Cells and Mediates Free Fatty Acid Stimulation of Incretin Secretion
- (2008) S. Edfalk et al. DIABETES
- Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells
- (2008) H. E. Parker et al. DIABETOLOGIA
- GPR119: “Double-Dipping” for Better Glycemic Control
- (2008) L. Lauffer et al. ENDOCRINOLOGY
- A Role for Intestinal Endocrine Cell-Expressed G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Peptide Release
- (2008) Zhi-Liang Chu et al. ENDOCRINOLOGY
- Pulmonary delivery of a GLP-1 receptor agonist, BMS-686117
- (2008) Feng Qian et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Targeted Ablation of Glucose-dependent Insulinotropic Polypeptide-producing Cells in Transgenic Mice Reduces Obesity and Insulin Resistance Induced by a High Fat Diet
- (2008) Matthew C. Althage et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Vaccination against GIP for the Treatment of Obesity
- (2008) Alma Fulurija et al. PLoS One
- Boc5, a Non-Peptidic Glucagon-Like Peptide-1 Receptor Agonist, Invokes Sustained Glycemic Control and Weight Loss in Diabetic Mice
- (2008) Haoran Su et al. PLoS One
- Measurements of Islet Function and Glucose Metabolism with the Dipeptidyl Peptidase 4 Inhibitor Vildagliptin in Patients with Type 2 Diabetes
- (2007) Koichiro Azuma et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Protective effects of GLP-1 analogues exendin-4 and GLP-1(9–36) amide against ischemia–reperfusion injury in rat heart
- (2007) David P. Sonne et al. REGULATORY PEPTIDES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started